- Home
- STTK vs WDH Comparison
STTK vs WDH Comparison
Compare STTK & WDH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STTK | WDH |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.3M | 596.7M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | STTK | WDH |
|---|---|---|
| Price | $6.10 | $1.58 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 522.7K | 165.0K |
| Earning Date | 05-01-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 3.57% |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.71 |
| P/E Ratio | ★ N/A | $9.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $1.29 |
| 52 Week High | $8.33 | $2.18 |
Technical Indicators
Market Signals| Indicator | STTK | WDH |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 45.92 |
| Support Level | $5.85 | $1.54 |
| Resistance Level | $6.81 | $1.74 |
| Average True Range (ATR) | 0.52 | 0.05 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 23.03 | 60.00 |
Price Performance
Historical ComparisonAbout STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.